University of Thessaly (UTH)
Μελέτη των γονιδίων και των πρωτεϊνών TACI και ICOS σε ασθενείς με λεμφοπαραγωγά σύνδρομα
Abstract
dc:descriptionPurpose: TACI and BAFFR might participate in the survival of CLL cells, protecting them from apoptosis through NF-κB. Mutations of TNFRSF13B, TNFRSF13C and ICOS genes have been associated with antibody deficiencies. The aim of this study was to detect the mutations of TNFRSF13B gene in Greek patients with antibody deficiencies and to determine the expression of TNFRSF13B/TACI, TNFRSF13C/BAFFR and ICOS on CLL cells and their contribution to the phenotype and the prognosis of the disease. Materials and methods: Samples from 53 patients with antibody deficiencies, 94 patients with CLL, 30 patients with NHL and 315 healthy individuals, were collected. The mRNA and protein levels of TNFRSF13B and TNFRSF13C were estimated by qRT-PCR and flow cytometry, respectively. BAFF and APRIL serum levels were estimated by ELISA. In CLL, the prognostic factors CD38 and the hypermutation status of IGHV gene were determined using flow cytometry and PCR-sequencing, respectively. CLL cells were stimulated by BAFF and APRIL and the apoptosis status was estimated by flow cytometry using an Annexin V-FITC/7-AAD (7-AAD) kit. The molecular analysis of TNFRSF13B gene was performed using PCR-sequencing and the detection of the polymorphisms TNFRSF13B-P251L, TNFRSF13B-V220A, TNFRSF13C-P21R and TNFRSF13C-H159Y using PCR-RFLP. Results: Μutations of TNFRSF13B gene are found both in patients and healthy individuals. CLL patients displayed signicantly lower expression of TACI (Median: 7,4%, IQR:2,1-20,8) compared to NHL patients (Median: 31,5, IQR: 9,6-61,8), p<0,001 and lower MFI of BAFFR compared to healthy controls (Median: 6,1 IQR:4,6-7,5 vs Median: 9,8 IQR:6,7-14,5 respectively). Serum BAFF was absent in the majority of CLL patients. Additionally, CLL cells with low or absent TACI expression were more susceptible to apoptosis in vitro after stimulation with all mitogens. TNFRSF13B/TACI expression and TNFRSF13C/BAFFR expression were not signicantly associated with the presence of autoimmunity, the infection risk and the prognosis of CLL. Conclusions: The mutations of TNFRSF13B are not causative factors for the apperance of antibody deficiencies. Τhe low TACI expression suggest that CLL may derive from CD5+ B cell populations rather than memory B cells and low BAFFR MFI could be used for the detection of minimal residual disease of CLL. These findings should be taken into account in the case of anti-TACI and anti-BAFFR therapeutic approaches.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mamara, Antigoni
- Μαμάρα, Αντιγόνη
Subjects
dc:subject × 24- Β χρόνια λεμφοκυτταρική λευχαιμία
- Πρωτοπαθείς ανοσοανεπάρκειες
- Απόπτωση
- Β λεμφοκύτταρα
- Χυμική ανοσία
- Υποδοχέας TACI
- Υποδοχέας ICOS
- Υποδοχέας BAFFR
- Ανοσοανεπάρκειες
- Λεμφοπαραγωγά σύνδρομα
- B chronic lymphocytic leukemia
- Primary immunodeficiencies
- Apoptosis
- B cells
- Humoral immunity
- TACI receptor
- ICOS receptor
- BAFFR receptor
- Immunodeficiencies
- Lymphoproliferative disorders
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35208